Feature Articles

Feature Articles

ASH Clinical News takes a deeper look at hot topics in medicine

Research espionage

The Spy Next Door?

Academic institutions and government organizations strive to prevent research espionage while maintaining open scientific collaborations For decades, the U.S. has fostered international research collaborations with...
In Myleloma, New Drugs, Skyrocketing Price Tags

In Myeloma, New Drugs, Skyrocketing Price Tags

In late February, seven pharmaceutical executives were called before the U.S. Senate Finance Committee to testify about the prices of brand-name prescription drugs, which...

Resurrecting the House Call

New at-home strategies for hematologic conditions offer improved outcomes and patient satisfaction Physician home visits have become a thing of the past: Nearly a century...

CMML: A Unique Overlap Syndrome Receiving Increased Attention

For many years, chronic myelomonocytic leukemia (CMML) has been treated as a form of myelodysplastic syndrome (MDS), despite its unique clinical and biological characteristics. “Everyone...

New Treatment Options Lead to New Questions in Acute Myeloid Leukemia

For the past 40 years, the standard remission induction treatment for patients with newly diagnosed acute myeloid leukemia (AML) who are candidates for intensive...

Reader Beware: Interpreting Clinical Trial Data

Numbers don’t lie – except when people cause them to.  With an abundance of scientific research being presented and published, many health-care practitioners rely on...

Planes, Trains, and VTEs

Simple recommendations can help mitigate risk for travel-related blood clots In November 2011, hematologist Suely Rezende, MD, PhD, deplaned from a flight from Lisbon to...

Is the Era of Traditional Chemotherapy for Hodgkin Lymphoma Over?

Treatment of Hodgkin lymphoma (HL) has been one of the greatest success stories in oncology, with the invention of radiation therapy and combination chemotherapy...

Finding Homes for Orphans

The unique challenges of researching, managing, and developing orphan drugs for rare diseases Rare diseases are having a moment, and not just in the field...

New Drug Approvals in Nonmalignant Hematology

In 2018, the U.S. Food and Drug Administration (FDA) set a record for the number of approvals for new therapies – or new indications...
Advertisement

Current Issue

July 2019 Bonus Mid-Year Edition, Volume 5, Issue 9

This issue features a look at research espionage, coverage from the ASCO and EHA annual meetings, and more.